Growth Metrics

Entera Bio (ENTX) Debt to Equity (2017 - 2025)

Entera Bio has reported Debt to Equity over the past 4 years, most recently at $0.03 for Q3 2025.

  • For the quarter ending Q3 2025, Debt to Equity changed N/A year-over-year to $0.03, compared with a TTM value of $0.03 through Sep 2025, changed N/A, and an annual FY2020 reading of $0.19, changed N/A over the prior year.
  • Debt to Equity came in at $0.03 for Q3 2025, up from $0.03 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.55 in Q1 2021 to a low of $0.03 in Q3 2021.